Effects of excitatory modulation on intrinsic properties of turtle motoneurons.
The purpose of this study was to quantify the effects of excitatory modulation on the intrinsic properties of motoneurons (MNs) in slices of spinal cord taken from the adult turtle. Responses were noted following application of an excitatory modulator: serotonin (5-HT), muscarine, trans-1-amino-1,3-cyclopentane dicarboxylic acid (tACPD), or all three combined. A sample of 44 MNs was divided into 2 groups, on the basis of whether MNs did (28/44) or did not (16/44) demonstrate a nifedipine-sensitive acceleration of discharge during a 2-s, intracellularly injected stimulus pulse. Such acceleration indicates the development of a plateau potential (PP). Excitatory modulation lowered the MNs' resting potential, increased input resistance, decreased rheobase, reduced several afterhyperpolarization values, and shifted the conventional, one-phase stimulus current-spike frequency (I-f) relation to the left. For both MN groups, the relative efficacy of excitatory modulation on both non-PP and PP MNs was generally in the following order: combined application > 5-HT approximately muscarine > tACPD. In many instances, the effects of modulation differed significantly for non-PP versus PP MNs, the most pronounced being in their I-f relation. To describe this difference, it was necessary to measure a two-phase relation. In PP MNs, excitatory modulation considerably increased the slope of the first (initial) phase and flattened the second (later) phase of this relation. The latter result bore similarities to that obtained in a previous study, which addressed MN firing behavior during fictive locomotion of the high-decerebrate cat.
Hornby
T George
TG
Department of Physiology, The University of Arizona, College of Medicine, Tucson, Arizona 85724-5051, USA.
McDonagh
Jennifer C
JC
Reinking
Robert M
RM
Stuart
Douglas G
DG
D000818:Animals; D003515:Cycloleucine / Q000031:analogs & derivatives / Q000494:pharmacology; D004338:Drug Combinations; D004594:Electrophysiology; D066298:In Vitro Techniques; D009046:Motor Neurons / Q000187:drug effects / Q000502:physiology*; D009116:Muscarine / Q000494:pharmacology; D009543:Nifedipine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013116:Spinal Cord / Q000166:cytology; D014426:Turtles
D004338:Drug Combinations; D003515:Cycloleucine; C036361:1-amino-1,3-dicarboxycyclopentane; D012701:Serotonin; D009116:Muscarine; D009543:Nifedipine